Viewing data from:

LEVALBUTEROL HYDROCHLORIDE

ANDA

LEVALBUTEROL HYDROCHLORIDE | A090297 | TEVA PHARMACEUTICALS USA

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 3 NDCs

Highest NADAC/Unit

$0.3772

per ml

Lowest NADAC/Unit

$0.2966

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093414856LEVALBUTEROL 1.25 MG/3 ML SOL	$0.3772	ML	Generic	—	2026-10-21
00093414656LEVALBUTEROL 0.63 MG/3 ML SOL	$0.3028	ML	Generic	—	2026-10-21
00093414556LEVALBUTEROL 0.31 MG/3 ML SOL	$0.2966	ML	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs1 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

FINE CHEMICALS CORP PTY LTDLEVALBUTEROL HYDROCHLORIDE

DMF 182362005

TAPI NL BVLEVALBUTEROL HYDROCHLORIDE

DMF 184332005

CIPLA LTDLEVALBUTEROL HYDROCHLORIDE USP

DMF 191312006

SUN PHARMACEUTICAL INDUSTRIES LTDLEVALBUTEROL HYDROCHLORIDE USP

DMF 276632014

OLON SPALEVALBUTEROL HYDROCHLORIDE

DMF 280342014

FDC LTDInactiveLEVALBUTEROL HYDROCHLORIDE

DMF 213942008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 0.0103% BASE

0 patents0 exclusivities▴

SOLUTION;INHALATION | Approved: Apr 26, 2013

No patent or exclusivity listings for this strength.

#002 — EQ 0.021% BASE

0 patents0 exclusivities▾

SOLUTION;INHALATION | Approved: Apr 26, 2013

#003 — EQ 0.042% BASE

0 patents0 exclusivities▾

SOLUTION;INHALATION | Approved: Apr 26, 2013